A5009024044- Chronic Disease Management Strategies
- Diabetes Management and Education
- Diabetes Treatment and Management
- Medication Adherence and Compliance
- Patient Satisfaction in Healthcare
- Blood Pressure and Hypertension Studies
- Pharmaceutical Practices and Patient Outcomes
- Diabetes Management and Research
MSD (Spain)
2020-2025
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent condition worldwide, with significant regional variability in prevalence estimates. This study aimed to determine the prevalence, demographic characteristics, and economic burden of MASLD, metabolic (MASL), steatohepatitis (MASH) Valencian Community region Spain. Methods: We conducted retrospective analysis electronic medical records from public healthcare database individuals aged over 24...
Diabetes is a major health care problem, reaching epidemic numbers worldwide. Reducing hemoglobin A1c (HbA1c) levels to recommended targets associated with marked decrease in the risk of type 2 diabetes mellitus (T2DM)-related complications. The implementation new technologies, particularly telemedicine, may be helpful facilitate self-care and empower people T2DM, leading improved metabolic control disease.This study aimed analyze effect home digital patient empowerment communication tool...
Abstract Aim To assess the experience with health care among patients type 2 diabetes (T2DM) and to evaluate patients’ demographic variables healthcare‐related characteristics which may affect their experience. Methods A cross‐sectional survey was delivered T2DM adults. Patient experiences were assessed ‘Instrument for Evaluation of Experience Chronic Patients’ (IEXPAC) questionnaire, a validated 12‐item survey, describes patient within last 6 months (items 1–11) hospitalization in 3 years...
Studies on treatment adherence to glucose-lowering drugs among patients with type 2 diabetes (T2D) including concomitant for other cardiovascular risk factors are scarce. We aimed estimate the prevalence of good all medications used control diabetes, hypertension and dyslipidemia analyse cardiometabolic its associated in T2D primary care (PC) setting.Observational, retrospective study conducted adult who were followed PC setting Spain. Patients classified as adherent a particular category if...
We aimed to evaluate the experience of patients with type 2 diabetes (T2DM) healthcare received in Spain. This was a retrospective, observational study T2DM cared for primary (PHC) centers. A cross-sectional analysis patients’ data performed using Instrument Evaluation Experience Chronic Patients (IEXPAC). total 475 were recruited from 36 PHC centers, which 248 (52.2%) completed IEXPAC questionnaire. The mean score (range 0–10) 7 points, an average “new relational model” 2.5 points....
Objective: T2DM patients often have multiple comorbidities which may impact patients’ management approach and treatment selection. This is the first study examining co-prevalence of such as CVD CKD (GFR <60 ml/min and/or UACR ≥ 30 mg/g) across in Spain using a well-validated local database (DB). Methods: Retrospective cross-sectional Spanish electronic records DB “Information System for Development Research Primary Care”, SIDIAP. Adult with were included comorbid conditions assessed...
Objective: To estimate the CKD (GFR <60 ml/min and/or UACR ≥ 30 mg/g) prevalence among T2DM patients and evaluate use of antidiabetic drugs based on renal function. Methods: Retrospective, cross-sectional study, analyzing data from Spanish electronic records database “Information System for Development Research in Primary Care, SIDIAP”, Jan, 2015 to Dec, 2016. The each stage chronic failure (CRF; GFR<60 mL/min) was evaluated with available GFR. Furthermore, adjusted RR 5 events...